Table 1 Patient characteristics by surgical approach
From: Single-port thoracoscopic anatomic resection for chronic inflammatory lung disease
SP-VATS (n = 65) | MP-VATS (n = 105) | P-value | |
|---|---|---|---|
Age, mean ± SD | 54.2 ± 12.6 | 52.4 ± 12.5 | 0.351 |
Sex, male (%) | 33 (50.8) | 56 (53.3) | 0.745 |
Etiology, n (%) | 0.325 | ||
Bronchiectasis | 31 (47.7) | 42 (40.0) | |
TB/NTM infection | 34 (52.3) | 63 (60.0) | |
Comorbidity, n (%) | |||
Hypertension | 12 (18.5) | 18 (17.1) | 0.827 |
Diabetes mellitus | 12 (18.5) | 34 (32.4) | 0.047 |
Coronary artery disease | 1 (1.5) | 3 (2.9) | 1.000 |
GERD | 0 | 3 (2.9) | 0.287 |
CKD/ESRD | 1 (1.5) | 3 (2.9) | 1.000 |
Liver cirrhosis | 1 (1.5) | 3 (2.9) | 1.000 |
Malignancy history | 3 (4.6) | 2 (1.9) | 0.372 |
Pulmonary function test, mean ± SD | |||
FEV1 (L) | 2.16 ± 0.84 | 2.27 ± 0.80 | 0.458 |
PEF1/FVC (%) | 76.9 ± 11.0 | 77.5 ± 10.3 | 0.755 |
Surgical indication, n (%) | 0.066 | ||
Hemoptysis | 36 (55.4) | 48 (45.7) | |
Recurrent pneumonia | 11 (16.9) | 16 (15.2) | |
Cavity, infected | 11 (16.9) | 13 (12.4) | |
Destroyed lobe | 2 (3.1) | 4 (3.8) | |
TB medication failure | 3 (4.6) | 23 (21.9) | |
Undetermined mass | 2 (3.1) | 1 (1.0) | |
Sidedness, n (%) | 0.281 | ||
Right | 35 (53.8) | 55 (52.4) | |
Left | 27 (41.5) | 49 (46.7) | |
Bilateral | 3 (4.6) | 2 (1.0) | |
Extent of resection, n (%) | 0.435 | ||
Upper lobe | 32 (49.2) | 63 (60.0) | |
Middle lobe | 9 (13.8) | 16 (15.2) | |
Lower lobe | 15 (23.1) | 20 (19.0) | |
Upper + middle lobe | 3 (4.6) | 2 (1.9) | |
Upper + lower lobe | 3 (4.6) | 3 (2.9) | |
Middle + lower lobe | 3 (4.6) | 1 (1.0) | |
Surgical procedure, n (%) | 0.226 | ||
Lobectomy | 27 (41.5) | 52 (49.5) | |
Segmentectomy | 28 (43.1) | 47 (44.8) | |
Lob. + Seg., ipsilateral | 6 (9.2) | 4 (3.8) | |
Lob. + Seg., bilateral | 1 (1.5) | 1 (1.0) | |
Seg. + Seg., ipsilateral | 0 | 1 (1.0) | |
Seg. + Seg., bilateral | 2 (3.1) | 0 | |
Bilobectomy | 1 (1.5) | 0 |